pulmonary nodules
Conditions
Interventions
Malignant nodule group:NA
Prodromal lesion group:NA
Sponsors
Dongzhimen Hospital, Beijing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the experimental group: 1: ? Aged between 18 and 75 years old 2: ? Gender unlimited 3: ? Those who meet the diagnostic criteria 4: ? Having clear surgical indications and requiring surgery 5: ? Postoperative pathology showed invasive cancer tissue 6: ? Has not received neoadjuvant treatment before surgery 7: ? Good compliance, able to complete the required inspections and inspections for the experiment 8: ? Informed consent, sign an informed consent form, and volunteer to participate in the trial. Inclusion criteria for the control group: Patients with lung nodules who are matched in gender and age, can complete various examinations, have informed consent to the trial, and have postoperative pathological indications of prodromal lesions were included as control group research subjects.
Exclusion criteria
Exclusion criteria: ? Merge other serious organ diseases, including decompensated chronic heart failure, decompensated chronic kidney disease, decompensated cirrhosis, uncontrolled blood and immune system diseases; ? Pregnant and lactating women; ? Individuals with mental disorders, depression, and suicidal tendencies; ? Elderly, weak, or unable to tolerate surgery for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pathology of pulmonary nodules; | — |
Secondary
| Measure | Time frame |
|---|---|
| Imaging features of pulmonary nodules; | — |
Countries
China
Contacts
Public ContactHongwu Wang
Dongzhimen Hospital, Beijing University of Chinese Medicine
Outcome results
None listed